Tanel Kiik
Tervise- ja tööminister 07.04.2022
nr 10.1-13/359-1
Sotsiaalministeerium
Austatud härra minister
Edastame Teile Euroopa Komisjoni voliniku Stella Kyriakidese 06.04.2022 kirja nr Ares(2022)
2624882 (COVID-19 teine tõhustusdoos).
Lugupidamisega
Marten Kokk
Esinduse asejuht Coreper I küsimustes
Lisad: voliniku kiri 2 lk
Tiiu Noobel +32 2227 4337
[email protected]
Rue Guimard 11/13 1040 Brüssel Tel: +32 2 227 39 10
[email protected] https://eu.mfa.ee/et/
Ref. Ares(2022)2624882 - 06/04/2022
European
Commission
STELLA KYRIAKIDES Rue de la Loi, 200
MEMBER OF THE EUROPEAN COMMISSION B-1049 Brussels - Berl 10/380
HEALTH AND FOOD SAFETY stella. kyriakides@ec. europa, eu
Brassels,
Dear Minister,
I would like to start by thanking you for the constructive and frank discussions last week in
Council.
Following up on our exchanges on COVID-19 vaccination, I tasked the European Medicines
Agency and the European Centre for Disease Prevention and Control to review currently
available evidence and the epidemiological situation, and to issue an opinion regarding the
possibility of a second booster dose. I am pleased to inform you that the European Medicines
Agency and the European Center for Disease Prevention and Control will today issue a joint
statement on this issue.
In its common position, based on the available scientific evidence, the Agencies have
concluded that a fourth dose of mRNA vaccine as a second booster could be administered for
people above 80 years of age due to the fragility of this population, the lower immune
response to vaccination and the higher risk of severe COVID-19.
With regard to immunocompetent adults of 60 to 80 years of age or population groups
identified as being at particular risk, while there is no indication of an imminent need for a
second booster, it may be considered in situations of increasing risk of severe COVID-19
among vaccinated individuals, because of possible signals of vaccine effectiveness waning or
a deteriorating epidemiological situation. Close vigilance and monitoring of such indications
at national level is essential.
For immunocompetent adults below 60 years of age, the Agencies consider that there is
currently no data available that would indicate a need to administer a fourth dose to this
population group.
I trust that this joint statement will support the national vaccination campaigns in Member
States that decide to offer second booster vaccinations to people 60 years of age and older as
well as to immunocompromised individuals. Let me stress that this statement is based on
currently available data and it cannot be excluded that further booster doses may be needed in
some or all age groups in anticipation of future waves, in preparation for the winter to come
or in view of additional scientific evidence on waning of vaccine protection or the possible
need for adapted vaccines.
It is therefore crucial that we continue to have a common, timely and closely coordinated
European strategy, based on solid scientific data, so that our citizens receive clear and
coherent guidance in this respect.
I would like to thank you once again for your cooperation and I count on your continued
commitment to working closely together to address the challenges from the ongoing
pandemic.
Yours sincerely,
Electronically signed on 06/04/2022 16:18 (UTC+02) in accordance with Article 11 of Commission Decision (EU) 2021/2121
Tiiu Noobel
From: Elen Nurme
Sent: Thursday, 7 April 2022 08:07
To: Tiiu Noobel
Subject: Fwd: Letter from EU Commissioner Stella Kyriakides for the attention of EU Health
Ministers - second booster dose
Attachments: Cover letter signed.pdf; Letter from Commissioner Kyriakides to Health Ministers on
second booster dose_signed.pdf
---------- Forwarded message ----------
From: Algis Kokka <
[email protected]>
Date: 6 April 2022 at 21:12:01 CEST
Subject: Fwd: Letter from EU Commissioner Stella Kyriakides for the attention of EU Health Ministers -
second booster dose
To: Triin Uusberg (SoM) <
[email protected]>,Agne Nettan-Sepp <
[email protected]>
Cc: Elen Nurme <
[email protected]>
Tere,
Edastan volinik Kyriakidese kirja ministrile seoses COVIDi teise tõhustusdoosiga.
Tervitades
Algis
---------- Forwarded message ----------
From: Marten Kokk <
[email protected]>
Date: 6 April 2022 at 20:23:08 CEST
Subject: Fwd: Letter from EU Commissioner Stella Kyriakides for the attention of EU Health Ministers -
second booster dose
To: Algis Kokka <
[email protected]>
Välisministeerium | Marten Kokk |
[email protected]
---------- Forwarded message ----------
From: SOLOMONIDOU Christiana <
[email protected]>
Date: 6 April 2022 at 16:27:42 CEST
Subject: Letter from EU Commissioner Stella Kyriakides for the attention of EU Health Ministers - second
booster dose
To:
[email protected],
[email protected],Ivanka.Tasheva@bg-
permrep.eu,
[email protected],
[email protected],Susanne.Szech-
[email protected],
[email protected],Marten Kokk <
[email protected]>,i.ghikas@rp-
1
grece.be,
[email protected],Tuuli-
[email protected],
[email protected],
[email protected],gabor.baranyai@mf
a.gov.hu,
[email protected],
[email protected],
[email protected],
[email protected],
[email protected],kathiana.bonello-
[email protected],
[email protected],
[email protected],pcl@reper-
portugal.be,
[email protected],
[email protected],
[email protected],tamara.weingerl-
[email protected]
Cc:
[email protected]
Dear Madam/Sir,
Please find attached a letter from the European Commissioner for Health and Food Safety, Mrs Stella Kyriakides,
addressed to the respective Minister for Health.
We would be grateful if you could transmit this correspondence to the attention of the Minister at your best
convenience.
Sincerely,
CHRISTIANA SOLOMONIDOU
Assistant to Ms Τove Ernst & Ms Karolina Herbout-Borczak
European Commission
Cabinet of Commissioner Stella Kyriakides
Health and Food Safety
BERL 10/400
B-1049 Brussels/Belgium
+32 229-90271
[email protected]
2